Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV.

HPV is a leading cause of cervical cancer in women, but 50% of people who develop the cancer are never tested. A self-collection test could help.

Screening and early detection, as well as the introduction of a human papillomavirus (HPV) vaccine, have fuelled transformative strides in decreasing the burden of cervical cancer for women and ...

The new offering utilizes the FDA-cleared HPV self-collection solution from Roche (SIX: RO, ROG; OTCQX: RHHBY), approved for use with Roche's cobas® HPV test ... screening for and diagnosing ...

Self-screenings for HPV are now being offered at Sonora Quest Laboratories in Arizona, the medical company announced on ...

HPV kits are a key step in India's self-reliance and achieving WHO’s target of screening 70% ... India’s indigenous HPV test kits are poised to redefine cervical cancer prevention and ...

Aotearoa New Zealand has embraced self-tests for cervical screening with a University of Otago–Ōtākou Whakaihu Waka-led study proving the method's feasibility. In 2023, the county's cervical ...

India launched its indigenously developed HPV test kits to screen for cervical cancer. Supported by the Department of ...

request to do self-collection and then actually do the collection on your own in a bathroom or in the examination room." Traditionally, cervical cancer screening involves a Pap smear test in which ...